BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30997129)

  • 1. Productivity costs of cardiovascular disease mortality across disease types and socioeconomic groups.
    Carter HE; Schofield D; Shrestha R
    Open Heart; 2019; 6(1):e000939. PubMed ID: 30997129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Productivity Costs of Premature Mortality Due to Cancer in Australia: Evidence from a Microsimulation Model.
    Carter HE; Schofield DJ; Shrestha R
    PLoS One; 2016; 11(12):e0167521. PubMed ID: 27942032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The long-term productivity impacts of all cause premature mortality in Australia.
    Carter HE; Schofield D; Shrestha R
    Aust N Z J Public Health; 2017 Apr; 41(2):137-143. PubMed ID: 27868363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The productivity gains associated with a junk food tax and their impact on cost-effectiveness.
    Carter HE; Schofield DJ; Shrestha R; Veerman L
    PLoS One; 2019; 14(7):e0220209. PubMed ID: 31329651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular disease burden due to productivity losses in European Society of Cardiology countries.
    Luengo-Fernandez R; Little M; Gray A; Torbica A; Maggioni AP; Huculeci R; Timmis AD; Vardas P; Leal J
    Eur Heart J Qual Care Clin Outcomes; 2024 Jan; 10(1):36-44. PubMed ID: 37280170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic burden from smoking-related diseases in Thailand.
    Bundhamcharoen K; Aungkulanon S; Makka N; Shibuya K
    Tob Control; 2016 Sep; 25(5):532-7. PubMed ID: 26427527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring the societal burden of cancer: the cost of lost productivity due to premature cancer-related mortality in Europe.
    Hanly P; Soerjomataram I; Sharp L
    Int J Cancer; 2015 Feb; 136(4):E136-45. PubMed ID: 25066804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Productivity costs and years of potential life lost associated with five leading causes of death: Evidence from Iran (2006-2010).
    Najafi F; Karami-Matin B; Rezaei S; Khosravi A; Soofi M
    Med J Islam Repub Iran; 2016; 30():412. PubMed ID: 28210577
    [No Abstract]   [Full Text] [Related]  

  • 9. Projected Costs of Informal Caregiving for Cardiovascular Disease: 2015 to 2035: A Policy Statement From the American Heart Association.
    Dunbar SB; Khavjou OA; Bakas T; Hunt G; Kirch RA; Leib AR; Morrison RS; Poehler DC; Roger VL; Whitsel LP;
    Circulation; 2018 May; 137(19):e558-e577. PubMed ID: 29632217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Cost of Lost Productivity Due to Premature Chagas Disease-Related Mortality: Lessons from Colombia (2010-2017).
    Olivera MJ; Palencia-Sánchez F; Riaño-Casallas M
    Trop Med Infect Dis; 2021 Jan; 6(1):. PubMed ID: 33513668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The personal and national costs of CVD: impacts on income, taxes, government support payments and GDP due to lost labour force participation.
    Schofield D; Shrestha R; Percival R; Passey M; Callander E; Kelly S
    Int J Cardiol; 2013 Jun; 166(1):68-71. PubMed ID: 22018513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Years of potential life lost and productivity costs due to premature mortality from six priority diseases in Tanzania, 2006-2015.
    Rumisha SF; George J; Bwana VM; Mboera LEG
    PLoS One; 2020; 15(6):e0234300. PubMed ID: 32516340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The economic costs of cardiovascular disease mortality in California, 1991: implications for public health policy.
    Fox P; Gazzaniga J; Karter A; Max W
    J Public Health Policy; 1996; 17(4):442-59. PubMed ID: 9009539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Socioeconomic variation in incidence of primary and secondary major cardiovascular disease events: an Australian population-based prospective cohort study.
    Korda RJ; Soga K; Joshy G; Calabria B; Attia J; Wong D; Banks E
    Int J Equity Health; 2016 Nov; 15(1):189. PubMed ID: 27871298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Productivity losses associated with cardiovascular disease: a systematic review.
    Gordois AL; Toth PP; Quek RG; Proudfoot EM; Paoli CJ; Gandra SR
    Expert Rev Pharmacoecon Outcomes Res; 2016 Dec; 16(6):759-769. PubMed ID: 27831848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Change in productivity losses due to premature deaths in Spain: 2005-2009].
    Peña Longobardo LM; Aranda-Reneo I; Oliva Moreno J; Vall Castello J
    Rev Esp Salud Publica; 2015; 89(1):39-50. PubMed ID: 25946584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tobacco smoking and risk of 36 cardiovascular disease subtypes: fatal and non-fatal outcomes in a large prospective Australian study.
    Banks E; Joshy G; Korda RJ; Stavreski B; Soga K; Egger S; Day C; Clarke NE; Lewington S; Lopez AD
    BMC Med; 2019 Jul; 17(1):128. PubMed ID: 31266500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling the impact of alcohol consumption on cardiovascular disease mortality for comparative risk assessments: an overview.
    Rehm J; Shield KD; Roerecke M; Gmel G
    BMC Public Health; 2016 Apr; 16():363. PubMed ID: 27121289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Projecting productivity losses for cancer-related mortality 2011 - 2030.
    Pearce A; Bradley C; Hanly P; O'Neill C; Thomas AA; Molcho M; Sharp L
    BMC Cancer; 2016 Oct; 16(1):804. PubMed ID: 27756270
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.